Herantis Pharma to Participate in the Upcoming Virtual Investor Conferences
Herantis Pharma Plc, Press Release, 30 August 2021 at 10:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and have a digital company presentation at the following investor conferences: Pareto Securities' 12[th] Annual Healthcare Conference 2021 – September 1-2, 2021 Virtual Presentation: September 1, 2021 at 11:30 – 12:00 EEST / 10:30 – 11:00 CEST Redeye Investor Forum – September 2, 2021 Virtual Presentation at 17: